RSS Feeds
Search

In-licensing

Oral, Topical or Transdermal products in any therapeutical area

APR Applied Pharma Research S.A.
APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration

Full description

APR is interested to evaluate in-licensing opportunities which fit with APR's strategy:

  1. Innovative product opportunities preferably where the innovation is given by the drug delivery system used;
  2. They are for Oral, Topical or Transdermal administration
  3. Patent Protected at least in EU and US

Development status

Phase II

Type of business relationship sought

We do not seek a specific type of business relationship: the structure of any business relationship we have entered was driven by the ultimate objective to always create a win-win relation.

Over time, APR has experienced several business relationships ranging from pure In-licensing deals to Joint Venture, Partnership or Co-development agreements.

Related reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us